Gold Miners Bear 3X Direxion (DUST) News $DUST Gold

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Gold Miners Bear 3X Direxion (DUST) News $DUST

Gold Miner ETFs Surging Ahead of Key Earnings Reports - ETF News And Commentary
Eric Dutram - Zacks Investment Research - Tue Feb 11, 5:00AM CST
Gold mining ETFs have been performing well, but the real test comes this week with earnings.

Will Extreme Bearish Sentiment Lift Gold?
Ron DeLegge - ETFG - Fri Dec 27, 4:35PM CST
The market hates gold and overly bearish sentiment toward precious metals points to an upcoming reversal in gold prices.

Gold and the 2004 New York Yankees
Ron DeLegge - ETFG - Sat Dec 14, 1:50AM CST
We examine similarities between today's gold market and the 2004 New York Yankees who choked their 3-0 lead to lose the World Series.

Bearishness in the Right Places Pays Big Dividends
Ron DeLegge - ETFG - Tue Nov 26, 12:31AM CST
Being selectively bearish, as opposed to blindly bearish, is how the smart bears make money. And despite a U.S. stock market at all-time highs, being a bear in one particular market has been a hugely profitable trade.

Is Gold Headed to $1,000 per Ounce?
Ron DeLegge - ETFG - Wed Nov 20, 11:53PM CST
Gold prices are falling fast and furious. And the correlation between the Federal Reserve's QE activity over the past two-years and gold prices has unwound.

Gold: A Sucker's Paradise
Ron DeLegge - ETFG - Sat Nov 09, 3:09AM CST
Over the past 2 years, gold has had 17 notable false breakouts. And each step of the way, gold keeps vacuuming in more and more sucker buyers.

Is More Pain Ahead for Gold Investors?
Chad Karnes - ETFG - Mon Oct 14, 7:13PM CDT
Gold bugs continue to buy at any price as they justify holding gold to counter the Fed's printing press. Meanwhile they have taken as much as a 40% haircut, ignoring what really matters in the precious metals markets.

Direxion Debuts Leveraged Junior Gold Miner ETFs - ETF News And Commentary
Eric Dutram - ZACKS - Wed Oct 09, 1:01PM CDT
Direxion is rounding out its miner ETF lineup with two junior gold mining leveraged funds.

Goldbugs Bitten Again by Precious Metals Rout
Ron DeLegge - ETFG - Thu Sep 26, 12:39AM CDT
Over the past two years, gold has had no less than 9 false breakouts. We chronicle each one and show you the profit opportunity.

Excessive Bullishness Foreshadowed Gold's Meltdown
Ron DeLegge - ETFG - Thu Sep 12, 10:14PM CDT
We examine real life examples of how ETFguide used sentiment extremes to make multiple profitable ETF trades on gold and mining stocks.

Is the Worst Really Over for Gold and Silver?
Ron DeLegge - ETFG - Thu Sep 05, 10:08PM CDT
Gold prices are down 26% and silver is down 45% over the past two years. And gold experts say the worst is over. Are they right?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

TSA PreCheck Study Reveals Time Savings and Travel Insights

Updated Category News Views 379

Understanding TSA PreCheck's Impact on Travelers The latest survey reveals some interesting insights about TSA PreCheck, especially concerning the time savings that members experience at security checkpoints. Conducted by Upgraded Points, this enlightening study assessed the experience of over 1,500 travelers to evaluate the true advantages of holding a TSA PreCheck...

Continue Reading
Intermap Technologies Enhances Geospatial Solutions with New Offering

Updated Category News Views 217

Intermap Technologies Announces New Prospectus Supplement DENVER – Intermap Technologies Corporation (TSX: IMP; OTCQB: ITMSF), a recognized leader in 3D geospatial products and intelligence solutions, has filed a prospectus supplement in the context of a strategically planned public offering. This initiative signifies a promising step forward, with the company aiming to...

Continue Reading
Urgent Investor Notice: Humacyte Legal Claims Investigation

Updated Category News Views 94

Critical Deadline for Humacyte Investors Approaches As time runs short, investors in Humacyte, Inc. (NASDAQ: HUMA) should pay attention. Faruqi & Faruqi, LLP, a prominent national securities law firm, is actively investigating claims on behalf of investors who have suffered losses exceeding $75,000 due to potential violations in federal securities laws. Understanding Your...

Continue Reading
Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab

Updated Category News Views 226

Empowering Women in Banking: Natalie Bartholomew at Alkami Co:lab Natalie Bartholomew, a highly recognized advocate for women in financial services, will be the featured speaker for the Women in Banking session at Alkami Co:lab 2026. Her expertise and passion are expected to inspire attendees and foster discussions around women's roles in the financial sector. Alkami...

Continue Reading
Investors Anticipate Strong Earnings from OPAL Fuels Soon

Updated Category News Views 161

OPAL Fuels Earnings Report Insights OPAL Fuels OPAL is preparing to release its quarterly earnings report soon, and investors are keenly interested in the results. As the anticipated date for this report approaches, it is essential for investors to stay informed and understand what the expectations are. Projected Earnings Overview Analysts project that OPAL Fuels will...

Continue Reading